The US Food and Drug Administration (FDA) has approved amphetamine extended-release oral suspension (Adzenys ER, Neos Therapeutics Inc) for attention-deficit ...
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...
Adderall, a combination of amphetamine salts, has been linked to enhanced cognitive function and academic performance, which, in part, has led to its "nonmedical" use - where it is taken on one's own ...
In October 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of amphetamine mixed salts—a drug category that includes Adderall, the stimulant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback